SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.390+4.5%Dec 24 12:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (565)10/8/1997 2:55:00 PM
From: BulbaMan   of 3576
 
The Post article's claim that telomerase inhibition won't work
as a cancer treatment for humans is erroneous. The study referred
to was actually sponsored by Geron and their scientists do not
believe the results are relevant to telomerase and human cancer.
It's been pretty well established that the mouse model is not
appropriate for evaluating the way telomerase works in people.
And given the substantial evidence indicating telomerase
inhibition would be a powerful human cancer therapy, it's absurd
to conclude that the mouse gene-knockout study knocks out the
telomerase/cancer theory.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News